-
Posted by
Two Blokes Apr 17 -
Filed in
Stock
-
4 views
The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR are likely to gain from the favorable factors.